Vincenzo Tombolini

Pubblicazioni

Titolo Pubblicato in Anno
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? CLINICAL NEUROLOGY AND NEUROSURGERY 2019
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2019
Treatment paths for localised prostate cancer in Italy: the results of a multidisciplinary, observational, prospective study (Pros-IT CNR) PLOS ONE 2019
Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer in Elderly Patients: Toxicity, Disease Control, and Survival Outcomes CLINICAL COLORECTAL CANCER 2018
Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer CANCER RESEARCH AND TREATMENT 2018
Definitive Chemoradiotherapy for Anal Carcinoma: Long-Term Results Based on Consistent Time-to-Event Endpoints ONCOLOGY 2018
Radiotherapy controversies and prospective in head and neck cancer: a literature-based critical review NEOPLASIA 2018
Screening program in ovarian cancer: a logical step in clinical management? A meta-analysis CURRENT PROBLEMS IN CANCER 2018
Fertility preservation in gynaecologic cancers ECANCERMEDICALSCIENCE 2018
Dose-dense weekly chemotherapy in advanced ovarian cancer: an updated meta-analysis of randomized controlled trials CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2018
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma JOURNAL OF HEMATOLOGY & ONCOLOGY 2018
Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma JOURNAL OF HEMATOLOGY & ONCOLOGY 2018
Moderate Hypofractionation in Patients with Low-risk Prostate Cancer: Long-term Outcomes ANTICANCER RESEARCH 2018
Psychological and functional effect of different primary treatments for prostate cancer: a comparative prospective analysis UROLOGIC ONCOLOGY 2018
Radiotherapy in indolent primary cutaneous B-cell lymphoma HEMATOLOGICAL ONCOLOGY 2018
The effect of postmastectomy radiation therapy on breast implants. Material analysis on silicone and polyurethane prosthesis ANNALS OF PLASTIC SURGERY 2018
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2018
Testosterone-mediates activation of androgenic signaling sustains in vitro the transformed and radioresistant phenotype of rhabdomysarcoma cell lines JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2018
Immune check-point in cervical cancer CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2018
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2018

ERC

  • LS4_12
  • LS7_1
  • LS7_6

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Radiobiologia- Radioterapia dei   tumori del testa collo - dell'apparato gastroenterico e uro-genitale - del polmone - Total body Irradiation

Keywords

Adult cancer
aggressive cancer
Medical Oncology
BASI BIOLOGICHE DEL CANCRO
3d conformal radiotherapy
imrt-sib
IMRT
cancer biology
conformal radiotherapy and stereotactic body radiotherapy

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma